A Phase II, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients with Stage IIIB or IV Non-Small Cell Lung Cancer
What is the purpose of this trial?
- 18 Years and older
- Infinity Pharmaceuticals
- June 2011
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale8017803